Diagnosis & Treatment For Prostate Cancer

September 2021.

Dr. Vorobiof Shares Risk Factors, Diagnosis & Treatment Options For Prostate Cancer Following on from earlier in the month when Maxwell Plus shared about prostate cancer, I welcome Dr Daniel Vorobiof to the blog. Dr. Vorobiof is a medical oncologist and the Medical Director of Belong.Life, developer of social network and navigator apps for patients, caregivers, and medical professionals, with apps currently available for cancer, multiple sclerosis and IBD. Dr Vorobiof has published more than 120 peer-reviewed articles in international medical journals. In this post, he gives us a comprehensive overview of prostate cancer.

The prostate is a walnut-sized gland found in men, situated below the bladder and in front of the rectum. It is connected to the urethra, a small tube that takes the urine and semen from the bladder and prostate to the penis. The prostate is involved in different functions of the body but the principal one is to create seminal fluid which helps in the production and transport of semen.

What is Prostate Cancer?

When healthy cells in the prostate start to change from normal cells and grow without any specific control, they form a growth, or tumor, in the prostatic area, which may be localized to one side of the prostate gland or present in both sides. If not treated, it can continue to grow without control and eventually might spread to other body parts, close or distant from the primary source.

Continue Reading >

Learn more about Prostate Cancer

Get Our Prostate Cancer ToolKit & Advice – Here

More Articles

Smart Menopause Support with Ask Elina – Powered by Belong’s AI

Ask Elina Helps Women Navigate perimenopause and Menopause….

Belong’s AI Technology Helps Women Navigate Menopause

A Canadian tech company is using Belong’s AI to help women get accurate menopause guidance….

New app uses Belong’s AI technology to fill gaps in menopause support

Belong.Life, the developer of AI-driven patient education and engagement solutions, has announced that its AI…
Skip to content